Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Rapid isolation of human CD34 hematopoietic stem cells--purging of human tumor cells.

Transplantation - 1 May 1992

Lebkowski J S, Schain L R, Okrongly D, Levinsky R, Harvey M J, Okarma T B

Abstract excerpt

Human CD34+ hematopoietic stem cells were purified using a new technology in which monoclonal antibodies are covalently immobilized on polystyrene surfaces. The CD34+ cell isolation scheme involved three sequential processes: (1) purification of bone marrow mononuclear cells; (2) enrichment of CD34+ cells using covalently immobilized soybean agglutinin; and (3) positive selection of CD34+ cells using polystyrene...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antibodies, Monoclonal
Share to Antigens, CD
Share to Breast Neoplasms

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Cell Adhesion

Share to Flow Cytometry

Share to Fluorescent Antibody Technique

Share to Hematopoietic Stem Cells

Share to Phenotype

Source

Identifiers

PMID: 1374943
DOI: 10.1097/00007890-199205000-00009

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Rapid isolation of human CD34 hematopoietic stem cells--purging of human tumor cells.PMID 1374943Read ↗

Phenotypic analysis and characterization of CD34+ cells from normal human bone marrow, cord blood, peripheral blood, and mobilized peripheral blood from patients undergoing autologous stem cell transplantation.Semantic proximity Read ↗

Separation of lectin-binding cells using polystyrene culture devices with covalently immobilized soybean agglutinin.Semantic proximity Read ↗

Sort-purification of human CD34 <sup>+</sup> CD90 <sup>+</sup> cells reduces target cell population and improves lentiviral transduction for gene therapySemantic proximity Read ↗

Improving Gene Therapy Efficiency through the Enrichment of Human Hematopoietic Stem CellsSemantic proximity Read ↗

Purification of Human CD34+CD90+ HSCs Reduces Target Cell Population and Improves Lentiviral Transduction for Gene TherapySemantic proximity Read ↗

Optimization of Fibronectin-Assisted Retroviral Gene Transfer into Human CD34 <sup>+</sup> Hematopoietic CellsSemantic proximity Read ↗

CD14+CD34low cells with stem cell phenotypic and functional features are the major source of circulating endothelial progenitors.Semantic proximity Read ↗

CD34 or S313 positive cells selection by avidin-biotin immunoadsorption.Semantic proximity Read ↗

Optimized processing of growth factor mobilized peripheral blood CD34+ products by counterflow centrifugal elutriation.Semantic proximity Read ↗

The gene encoding the stem cell antigen, CD34, is conserved in mouse and expressed in haemopoietic progenitor cell lines, brain, and embryonic fibroblastsSemantic proximity Read ↗

CD34 Splice Variant: An Attractive Marker for Selection of Gene-Modified CellsSemantic proximity Read ↗

Anti‐VEGFR‐2 scFvs for Cell Isolation. Single‐Chain Antibodies Recognizing the Human Vascular Endothelial Growth Factor Receptor‐2 (VEGFR‐2/flk‐1) on the Surface of Primary Endothelial Cells and Preselected CD34 + Cells from Cord BloodSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.